Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) in the liver-update 2020 WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS.
Liver; World Federation for Ultrasound in Medicine and Biology; Contrast-enhanced ultrasound; Guideline
The present, updated document describes the fourth iteration of recommendations for the hepatic use of contrast-enhanced ultrasound, first initiated in 2004 by the European Federation of Societies for Ultrasound in Medicine and Biology. The previous updated editions of the guidelines reflected changes in the available contrast agents and updated the guidelines not only for hepatic but also for non-hepatic applications. The 2012 guideline requires updating as, previously, the differences in the contrast agents were not precisely described and the differences in contrast phases as well as handling were not clearly indicated. In addition, more evidence has been published for all contrast agents. The update also reflects the most recent developments in contrast agents, including U.S. Food and Drug Administration approval and the extensive Asian experience, to produce a truly international perspective. These guidelines and recommendations provide general advice on the use of ultrasound contrast agents (UCAs) and are intended to create standard protocols for the use and administration of UCAs in liver applications on an international basis to improve the management of patients.
Dietrich CF; Nolsøe CP; Barr RG; Berzigotti A; Burns PN; Cantisani V; Chammas MC; Chaubal N; Choi BI; Clevert D; Cui X; Dong Y; D'Onofrio M; Fowlkes JB; Gilja OH; Huang P; Ignee Andre; Jenssen C; Kono Y; Kudo M; Lassau N; Lee WJ; Lee JY; Liang P; Lim A; Lyshchik A; Meloni MF; Correas JM; Yasunori M; Moriyasu F; Nicolau C; Piscaglia F; Saftoiu A; Sidhu PS; Sporea I; Torzilli G; Xie X; Zheng R
Ultrasound in Medicine & Biology
2020
2020-07-22
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
journalArticle
<a href="http://doi.org/10.1016/j.ultrasmedbio.2020.04.030" target="_blank" rel="noreferrer noopener">10.1016/j.ultrasmedbio.2020.04.030</a>
Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver - update 2020 - WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS.
The present, updated document describes the fourth iteration of recommendations for the hepatic use of contrast enhanced ultrasound (CEUS), first initiated in 2004 by the European Federation of Societies for Ultrasound in Medicine and Biology (EFSUMB). The previous updated editions of the guidelines reflected changes in the available contrast agents and updated the guidelines not only for hepatic but also for non-hepatic applications.The 2012 guideline requires updating as previously the differences of the contrast agents were not precisely described and the differences in contrast phases as well as handling were not clearly indicated. In addition, more evidence has been published for all contrast agents. The update also reflects the most recent developments in contrast agents, including the United States Food and Drug Administration (FDA) approval as well as the extensive Asian experience, to produce a truly international perspective.These guidelines and recommendations provide general advice on the use of ultrasound contrast agents (UCA) and are intended to create standard protocols for the use and administration of UCA in liver applications on an international basis to improve the management of patients.
Dietrich CF; Nolsøe CP; Barr RG; Berzigotti A; Burns PN; Cantisani V; Chammas MC; Chaubal N; Choi BI; Clevert D; Cui X; Dong Y; D'Onofrio M; Fowlkes JB; Gilja OH; Huang P; Ignee Andre; Jenssen C; Kono Y; Kudo M; Lassau N; Lee WJ; Lee JY; Liang P; Lim A; Lyshchik A; Meloni MF; Correas JM; Yasunori M; Moriyasu F; Nicolau C; Piscaglia F; Saftoiu A; Sidhu PS; Sporea I; Torzilli G; Xie X; Zheng R
Ultraschall in der Medizin (Stuttgart, Germany : 1980)
2020
2020-07-24
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
journalArticle
<a href="http://doi.org/10.1055/a-1177-0530" target="_blank" rel="noreferrer noopener">10.1055/a-1177-0530</a>
How to perform Contrast-Enhanced Ultrasound (CEUS).
cancer; guidelines; teaching; ultrasonography
"How to perform contrast-enhanced ultrasound (CEUS)" provides general advice on the use of ultrasound contrast agents (UCAs) for clinical decision-making and reviews technical parameters for optimal CEUS performance. CEUS techniques vary between centers, therefore, experts from EFSUMB, WFUMB and from the CEUS LI-RADS working group created a discussion forum to standardize the CEUS examination technique according to published evidence and best personal experience. The goal is to standardise the use and administration of UCAs to facilitate correct diagnoses and ultimately to improve the management and outcomes of patients.
Dietrich Christoph F; Averkiou Michalakis; Nielsen Michael Bachmann; Barr Richard G; Burns Peter N; Calliada Fabrizio; Cantisani Vito; Choi Byung; Chammas Maria C; Clevert Dirk-Andre; Claudon Michel; Correas Jean Michel; Cui Xin-Wu; Cosgrove David; D'Onofrio Mirko; Dong Yi; Eisenbrey JohnR; Fontanilla Teresa; Gilja Odd Helge; Ignee Andre; Jenssen Christian; Kono Yuko; Kudo Masatoshi; Lassau Nathalie; Lyshchik Andrej; Franca Meloni Maria; Moriyasu Fuminori; Nolsoe Christian; Piscaglia Fabio; Radzina Maija; Saftoiu Adrian; Sidhu Paul S; Sporea Ioan; Schreiber-Dietrich Dagmar; Sirlin Claude B; Stanczak Maria; Weskott Hans-Peter; Wilson Stephanie R; Willmann Juergen Karl; Kim Tae Kyoung; Jang Hyun-Jung; Vezeridis Alexandar; Westerway Sue
Ultrasound international open
2018
2018-01
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
<a href="http://doi.org/10.1055/s-0043-123931" target="_blank" rel="noreferrer noopener">10.1055/s-0043-123931</a>